AAAAAA
Results: 1-25/33
Authors:
GILES FJ
Citation: Fj. Giles, MONOCYTE-MACROPHAGES, GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR, AND PROLONGED SURVIVAL AMONG PATIENTS WITH ACUTE MYELOID-LEUKEMIA AND STEM-CELL TRANSPLANTS, Clinical infectious diseases, 26(6), 1998, pp. 1282-1289
Authors:
KANTARJIAN HM
GILES FJ
OBRIEN SM
TALPAZ M
Citation: Hm. Kantarjian et al., CLINICAL COURSE AND THERAPY OF CHRONIC MYELOGENOUS LEUKEMIA WITH INTERFERON-ALPHA AND CHEMOTHERAPY, Hematology/oncology clinics of North America, 12(1), 1998, pp. 31
Authors:
GILES FJ
KANEMAKI TJ
SCHRECK RR
QASABIAN L
FUERST MP
LIM SW
Citation: Fj. Giles et al., TRANSLOCATION (3-21-8)(Q21-Q22-Q22) IN A PATIENT WITH ACUTE MYELOID-LEUKEMIA - A CASE-REPORT AND REVIEW OF PROGNOSTIC INDICATORS, Cancer genetics and cytogenetics, 104(1), 1998, pp. 66-69
Authors:
GILES FJ
OBRIEN SM
KEATING MJ
Citation: Fj. Giles et al., CHRONIC LYMPHOCYTIC-LEUKEMIA IN (RICHTERS) TRANSFORMATION, Seminars in oncology, 25(1), 1998, pp. 117-125
Authors:
GILES FJ
SHAH PM
TEE GY
WANG LX
CAVILEZ A
SUPANDIMAN I
RANA F
RAPOPORT BL
FAHED Z
AZIZ Z
SUHARTI C
CHEN YC
TAN P
SALIM KA
KOCHUPILLAI V
GONZAGA M
ALI NM
ADVANI SH
PATEL M
CHEN S
TORRES R
TAM J
LYNOTT AM
LIM SW
FUERST MP
KUSUANCO DA
POOVALINGAM V
Citation: Fj. Giles et al., ADVERSE-EFFECTS OF ALPHA-2B INTERFERON (IFN) IN PATIENTS WITH PH-PHASE CHRONIC MYELOGENOUS LEUKEMIA ENROLLED IN THE INTERNATIONAL ONCOLOGY STUDY-GROUP (IOSG) CML1 STUDY( EARLY CHRONIC), British Journal of Haematology, 102(1), 1998, pp. 184-184
Authors:
GILES FJ
KUSUANCO D
LYNOTT A
SHAH PM
WANG LX
SUPANDIMAN I
POOVALINGAM V
RANA F
AZIZ F
CHEN YC
DUTOIT PJ
JANUSZEWICZ H
TEE GY
WOLF M
SUMANTRI R
ALOMARI K
TIAN D
BEZWODA WR
ABDI E
GONZAGA M
FAHED F
FOURIE LS
RUFF P
POOL R
KIM HC
PARIKH PM
KIM KY
HO BS
TAN P
LEE SN
TIEN SL
WIJONO A
LOBERIZA S
LEE GH
KIM SY
HO CH
BAYLON H
AHN MJ
THOMAS M
WOLF M
TIEN HF
AYDOGDU I
TAM J
LIM SW
CAVILEZ A
Citation: Fj. Giles et al., PROGNOSTIC FACTORS IN PATIENTS WITH PH-PHASE CHRONIC MYELOGENOUS LEUKEMIA (CML) ENROLLED IN THE INTERNATIONAL ONCOLOGY STUDY-GROUP (IOSG) CML1 STUDY( EARLY CHRONIC), British Journal of Haematology, 102(1), 1998, pp. 187-187
Authors:
JEWELL AP
WORMAN CP
GILES FJ
GOLDSTONE AH
Citation: Ap. Jewell et al., SERUM LEVELS OF TNF, IL-6 AND SCD23 CORRELATE WITH CHANGES IN LYMPHOCYTE COUNT IN PATIENTS WITH B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA RECEIVING INTERFERON-ALPHA THERAPY, Leukemia & lymphoma, 24(3-4), 1997, pp. 327-333
Authors:
GILES FJ
WAXMAN AD
NGUYEN KN
FUERST MP
KUSUANCO DA
FRANCO MM
BIERMAN H
LIM SW
Citation: Fj. Giles et al., COMPARISON OF TC-99M SESTAMIBI AND IN-111 OCTREOTIDE IMAGING IN A PATIENT WITH EWINGS-SARCOMA BEFORE AND AFTER STEM-CELL TRANSPLANTATION, Cancer, 80(12), 1997, pp. 2478-2483
Authors:
WIRT DP
GILES FJ
OKEN MM
SOLALCELIGNY P
BECK JR
Citation: Dp. Wirt et al., COST-EFFECTIVENESS OF INTERFERON-ALPHA ADDED TO CHEMOTHERAPY FOR HIGHTUMOR BURDEN FOLLICULAR NON-HODGKINS-LYMPHOMA, Blood, 90(10), 1997, pp. 843-843
Authors:
JEWELL AP
GILES FJ
Citation: Ap. Jewell et Fj. Giles, CUTANEOUS MANIFESTATION OF LEISHMANIASIS 40 YEARS AFTER EXPOSURE IN APATIENT WITH CHRONIC LYMPHOCYTIC-LEUKEMIA, Leukemia & lymphoma, 21(3-4), 1996, pp. 347-349
Authors:
LOOK RM
LIM SW
WAXMAN AD
GUPTA PK
FUERST MMP
KUSUANCO DA
LAWRENCE GN
GILES FJ
Citation: Rm. Look et al., TC-99M SESTAMIBI SCANNING IN MULTIPLE-MYELOMA STEM-CELL TRANSPLANTATION, Leukemia & lymphoma, 20(5-6), 1996, pp. 453-456
Authors:
LIM SW
FALK RE
LOOK RM
FUERST MM
LAWRENCE GN
KUSUANCO DA
GILES FJ
Citation: Sw. Lim et al., TRANSLOCATION (12-15)(P13-Q13) IN A PATIENT WITH RELAPSED ACUTE MYELOID-LEUKEMIA, Cancer genetics and cytogenetics, 86(2), 1996, pp. 165-167
Authors:
GILES FJ
LIM SW
VILLALON A
BAPSY PP
CHAIMONGKOL B
RAAFAT J
JOOTAR S
ISMAIL K
KHALID H
ADNAN AF
HASHEM T
FRANCO MM
Citation: Fj. Giles et al., COMPARISON OF HISTOLOGIC DISTRIBUTION END EXTRANODAL INVOLVEMENT IN INTERMEDIATE AND HIGH-GRADE NON-HODGKINS-LYMPHOMA IN ASIAN, EGYPTIAN, AND US PATIENT COHORTS, Blood, 88(10), 1996, pp. 3460-3460
Authors:
GILES FJ
AVVISATI G
SUPANDIMAN I
WICKHAM NR
SUH C
SUHARTI C
MUTHALIB A
TAN P
LEE CH
KUCHOPILLAI V
HARRYANTO A
LEKHAKULA A
RAPOPORT BL
SAGAR TG
AKAN H
RAAFAT J
USKENT N
PARIKH PM
SALIM KA
RADHESHYAM D
RUFF P
HO CH
CHEN YC
SUWANSELA N
KANG JH
SMRUTI BK
PATEL M
KIM SY
TIAN D
THAMPRASIT T
LEE KB
GONZAGA M
SUMANTRI R
NARCISO C
WANG PN
CHASEN MR
RAATS JI
CHAO TY
ANGGRAENI E
RAGNUHARDI D
ONA N
GOPAL BK
COMIA S
FUERST MP
LIM SW
FRANCO MM
KUSUANCO DA
Citation: Fj. Giles et al., COMPARISON OF INITIAL CLINICAL CHARACTERISTICS BETWEEN ASIAN AND ITALIAN MULTIPLE-MYELOMA (MM) PATIENTS ENTERING THE INTERNATIONAL ONCOLOGYSTUDY-GROUP (IOSG) MM1 AND THE ITALIAN MM STUDY-GROUP PROTOCOLS, Blood, 88(10), 1996, pp. 3586-3586
Authors:
GILES FJ
WICKHAM NR
RAPOPORT BL
FONG W
SOMLO G
FUERST MP
KUSUANCO DA
FRANCO MM
FISCHER DA
HUGHLETT CE
LIM SW
Citation: Fj. Giles et al., CYCLOPHOSPHAMIDE, ETOPOSIDE, VINCRISTINE, ADRIAMYCIN AND DEXAMETHASONE (CEVAD) RGM-CSF IS AN EFFECTIVE REGIMEN IN REFRACTORY OR RELAPSED MULTIPLE-MYELOMA (MM), Blood, 88(10), 1996, pp. 3604-3604
Authors:
GILES FJ
OBRIEN S
KANTARJIAN HM
PLUNKETT W
ESTEY E
BERAN M
YANG LY
SEYMOUR J
ROBERTSON LE
LERNER S
KEATING MJ
Citation: Fj. Giles et al., SEQUENTIAL CISPLATINUM, FLUDARABINE, AND ARABINOSYL CYTOSINE (PFA) INPATIENTS WITH PRIOR FLUDARABINE THERAPY FOR CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL) - A PHASE-II STUDY, Blood, 88(10), 1996, pp. 3605-3605
Authors:
GILES FJ
OBRIEN S
KANTARJIAN HM
ESTEY E
KOLLER C
PLUNKETT W
YANG LY
SEYMOUR J
ROBERTSON LE
LERNER S
KEATING MJ
Citation: Fj. Giles et al., SEQUENTIAL CISPLATINUM, FLUDARABINE, AND ARABINOSYL CYTOSINE (PFA) ORCYCLOPHOSPHAMIDE, FLUDARABINE AND ARABINOSYL CYTOSINE (CFA) IN PATIENTS WITH RICHTERS-SYNDROME (RS) - A PILOT-STUDY, Blood, 88(10), 1996, pp. 360-360
Authors:
GILES FJ
LIM SW
KANEMAKI TJ
HAMBURG SI
TAM JT
HEIFETZ LJ
FRANCO MM
MCANDREW PF
DECKER RW
FUERST MMP
ROSENBLOOM BE
GREEN LM
ROSENFELT FP
LYMAN SD
Citation: Fj. Giles et al., FLT3 LIGAND SERUM LEVELS IN PATIENTS RECEIVING CYTOTOXIC CHEMOTHERAPY, Blood, 88(10), 1996, pp. 1377-1377
Authors:
ELLIS GK
HUTCHINS L
JIMENEZMARTIN M
PECORA AL
BARNADAS A
MEISENBERG B
NABHOLTZ JM
CORTESFUNES H
RIFKIN R
CHANG AYC
GARRISON L
GEORGE C
GILES FJ
Citation: Gk. Ellis et al., PHASE-III DOUBLE-BLIND RANDOMIZED STUDY OF PIXY321 VERSUS GCSF AFTER CEP FOR BREAST OR OVARIAN-CARCINOMA, Blood, 88(10), 1996, pp. 1783-1783
Authors:
GILES FJ
KANEMAKI TJ
OTSUKI JT
PON DF
HEIFETZ LJ
MCANDREW PF
KOH HA
LIM SW
Citation: Fj. Giles et al., SINGLE-AGENT CEFTAZIDIME (CTZ) VS MULTIPLE ANTIBIOTICS IN THE TREATMENT OF CHEMOTHERAPY-INDUCED NEUTROPENIC FEVER (NF) - IMPACT OF A CLINICAL PATHWAY IN ANTIBIOTIC UTILIZATION AND ANTIBIOTIC-RESISTANCE, Blood, 88(10), 1996, pp. 2000-2000
COST-EFFECTIVENESS OF INTERFERON-ALPHA AND CONVENTIONAL CHEMOTHERAPY IN CHRONIC MYELOGENOUS LEUKEMIA
Authors:
KATTAN MW
INOUE Y
GILES FJ
TALPAZ M
OZER H
GUILHOT F
ZUFFA E
HUBER SL
BECK JR
Citation: Mw. Kattan et al., COST-EFFECTIVENESS OF INTERFERON-ALPHA AND CONVENTIONAL CHEMOTHERAPY IN CHRONIC MYELOGENOUS LEUKEMIA, Annals of internal medicine, 125(7), 1996, pp. 541
Authors:
GILES FJ
Citation: Fj. Giles, CURRENT THERAPY OF REFRACTORY MULTIPLE-MYELOMA, Stem cells, 13, 1995, pp. 88-105
Authors:
JEWELL AP
LYDYARD PM
WORMAN CP
GILES FJ
GOLDSTONE AH
Citation: Ap. Jewell et al., GROWTH-FACTORS CAN PROTECT B-CHRONIC LYMPHOCYTIC-LEUKEMIA CELLS AGAINST PROGRAMMED CELL-DEATH WITHOUT STIMULATING PROLIFERATION, Leukemia & lymphoma, 18(1-2), 1995, pp. 159-162
Authors:
GILES FJ
Citation: Fj. Giles, REFRACTORY MULTIPLE-MYELOMA - RECENT ADVANCES IN THERAPY, Hematologic pathology, 9(3-4), 1995, pp. 121-140
Authors:
LOOK RM
LIM SW
SCHRECK RR
LEE S
FUERST MP
LAWRENCE GN
KUSUANCO DA
KESSLER CE
GILES FJ
Citation: Rm. Look et al., BURKITT TRANSLOCATION (8-22)(Q24-Q11) IN A PATIENT WITH MULTIPLE-MYELOMA, Cancer genetics and cytogenetics, 82(2), 1995, pp. 100-102